Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Texas: Complete PA Guide with Appeal Scripts

Answer Box: Getting Dojolvi Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Dojolvi (triheptanoin) with molecular confirmation of LC-FAOD via genetic testing or enzyme activity. In Texas, you have strong appeal rights including expedited external review through Independent Review Organizations. First step today: Contact your board-certified medical geneticist
6 min read

How to Get Cometriq (cabozantinib) Covered by UnitedHealthcare in Michigan: Complete PA Guide with Forms and Appeals

Getting Cometriq (cabozantinib) covered by UnitedHealthcare in Michigan requires prior authorization for metastatic medullary thyroid carcinoma (MTC) or progressive thyroid cancers after failed step therapy. Submit via the UHC Provider Portal with diagnosis confirmation, or call 866-889-8054. If denied, you have 180 days for internal appeals and 127 days for
5 min read

How to Get Breyanzi (lisocabtagene maraleucel) Covered by UnitedHealthcare in Georgia: Prior Authorization Guide and Appeals Process

Answer Box: Getting Breyanzi Covered by UnitedHealthcare in Georgia UnitedHealthcare requires prior authorization for Breyanzi (lisocabtagene maraleucel) CAR-T therapy through OptumRx. Submit via the UHC Provider Portal with diagnosis documentation, prior therapy failures, and medical necessity justification. If denied, you have 180 days for internal appeals and 60 days for
5 min read

How to Get Revlimid (lenalidomide) Covered by UnitedHealthcare in Florida: Complete PA Guide and Appeal Process

Answer Box: Getting Started Today UnitedHealthcare requires prior authorization (PA) for Revlimid (lenalidomide) in Florida through OptumRx, with mandatory REMS program enrollment. Your fastest path to approval: (1) Ensure your prescriber is REMS-certified and submits PA via the UnitedHealthcare provider portal with complete clinical documentation, (2) Enroll in the Lenalidomide
5 min read

Renewing Mycapssa (Octreotide Oral) Approval with UnitedHealthcare in North Carolina: Complete 2025 Guide

Answer Box: Mycapssa Renewal Essentials UnitedHealthcare requires annual reauthorization for Mycapssa (oral octreotide) in North Carolina, approving 12-month renewals based on documented clinical response—typically normalized IGF-1 levels and symptom improvement. Submit renewal requests 30-60 days before expiration via the OptumRx Provider Portal or fax (866-889-8054) with recent labs, treatment
6 min read

How to Get Humate-P Covered by UnitedHealthcare in Washington: Prior Authorization, Appeals & State Protections

Answer Box: Getting Humate-P Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization (PA) for Humate-P (antihemophilic factor/vWF complex) with step therapy mandating desmopressin (DDAVP) trial first unless contraindicated. Submit PA requests via the UHC Provider Portal or call OptumRx at 1-800-711-4555. Standard processing takes 7 days; expedited requests
6 min read

How to Get Cimzia (Certolizumab Pegol) Covered by UnitedHealthcare in Ohio: Prior Authorization, Appeals, and Success Strategies

Answer Box: Getting Cimzia Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Cimzia (certolizumab pegol) in Ohio, with 12-month approvals based on meeting step therapy requirements and safety screenings. Your fastest path: 1) Submit PA via UnitedHealthcare provider portal with TB/hepatitis B screening, prior therapy failures, and
5 min read

How to Get Kesimpta (Ofatumumab) Covered by UnitedHealthcare in Pennsylvania: Prior Authorization, Appeals, and Cost-Saving Strategies

Quick Answer: Getting Kesimpta Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Kesimpta (ofatumumab) through OptumRx, typically mandating step therapy with other disease-modifying therapies first. Your neurologist submits the PA via UHC Provider Portal with MS diagnosis (ICD-10 G35), prior DMT failures, and baseline labs. Standard decisions take
6 min read